CM
EVH icon

Crestline Management’s Evolent Health EVH Stock Holding History

Crestline Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-335,000
Closed -$2.41M – 60
2019
Q3 		$2.41M Buy
335,000
+87,500
+35% +$628K 0.39% 46
2019
Q2 		$1.97M Buy
+247,500
New +$2.93M 0.27% 44

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Crestline Management's EVH Position: Q4 2019 in Review

Crestline Management sold out of Evolent Health (EVH) in Q4 2019, closing a stake of 335,000 shares — an estimated $2.41M sold.

Crestline Management first reported a position in EVH in Q2 2019 and held it in 2 quarters. The position peaked at $2.41M in Q3 2019. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

  • Crestline Management reported no remaining Evolent Health position as of Q4 2019 after selling out during the quarter.
  • Crestline Management sold 335,000 Evolent Health shares in Q4 2019, an estimated $2.41M.
  • Crestline Management first reported a position in Evolent Health in Q2 2019 and held it in 2 quarters.
  • Crestline Management's Evolent Health position peaked at $2.41M in Q3 2019.
  • 167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Crestline Management's 13F filing for Q4 2019, filed 12 Feb 2020.